苏州鹏旭医药科技有限公司
mail中文English
Today:
        Pengxu focuses on the development of APIs with high technical barrier and supplies the related intermediates. Based on our internal “RTPD”(Risk-Taking Product Development)and “CCPS” (Chemistry, Cost, Patent, and Safety) systems, we select right target molecules, develop cost-effective non-infringing process well ahead of other competitors, and work with our partners on novel polymorph forms. Through API technology licensing and key intermediates supplying, we support our customers’ API production and help them to secure a leading status in First-to-File type of generic.
        Pengxu was established in 2011 and our R&D center is located in Suzhou, China. We currently have a R&D team of 30 scientists, including 4 PhDs and a dedicated analytical team. We have 1700 m2 lab space, necessary equipments including 5 HPLC&GC systems, kilo labs, and two sites that can handle industrial scale intermediate production.
Suzhou PengXu PharmaTech is award the title of hig... 2016-12-23
By 2015,PengXu PharmaTech was gaved 2 patent appli... 2015-6-19
By 2015,filed 10 process patent applications and c... 2015-6-19
HomeAboutProductsNewsJobsContact
Copyrights:Solectron suzhou great medical technology Co., LTD 3rd Floor, Building 7, 2358 ChangAn Road, Wujiang Suzhou, JiangSu, 215200,  China
Tel:0512-88812899 support:Epower Net manage